Zhuhai Rundu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Zhuhai Rundu Pharmaceutical has a total shareholder equity of CN¥1.2B and total debt of CN¥586.9M, which brings its debt-to-equity ratio to 48.6%. Its total assets and total liabilities are CN¥2.2B and CN¥1.0B respectively. Zhuhai Rundu Pharmaceutical's EBIT is CN¥51.5M making its interest coverage ratio 3.7. It has cash and short-term investments of CN¥223.4M.
Key information
48.6%
Debt to equity ratio
CN¥586.87m
Debt
Interest coverage ratio | 3.7x |
Cash | CN¥223.36m |
Equity | CN¥1.21b |
Total liabilities | CN¥1.03b |
Total assets | CN¥2.24b |
Recent financial health updates
No updates
Recent updates
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20
May 29There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings
May 05There's Reason For Concern Over Zhuhai Rundu Pharmaceutical Co., Ltd.'s (SZSE:002923) Massive 32% Price Jump
Mar 05Financial Position Analysis
Short Term Liabilities: 002923's short term assets (CN¥871.6M) exceed its short term liabilities (CN¥417.2M).
Long Term Liabilities: 002923's short term assets (CN¥871.6M) exceed its long term liabilities (CN¥610.6M).
Debt to Equity History and Analysis
Debt Level: 002923's net debt to equity ratio (30.1%) is considered satisfactory.
Reducing Debt: 002923's debt to equity ratio has increased from 4.8% to 48.6% over the past 5 years.
Debt Coverage: 002923's debt is well covered by operating cash flow (39.8%).
Interest Coverage: 002923's interest payments on its debt are well covered by EBIT (3.7x coverage).